Insider: Scalzo Richard William SVP, Head of Finance & Admin. - Dyne Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 122,330 | 0 | 122,330 |
| Value | $1,538,911.40 | $0.00 | $1,538,911.40 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/11/2025 | DDS | 1,343 | Direct | COM | $11.38 | $15,283.34 | 122,330 |
| 03/05/2025 | DDS | 917 | Direct | COM | $11.83 | $10,848.11 | 123,673 |
| 02/18/2025 | DDS | 2,488 | Direct | COM | $13.95 | $34,707.60 | 124,590 |
| 12/11/2024 | DDS | 1,455 | Direct | COM | $28.12 | $40,914.60 | 127,078 |
| 11/18/2024 | DDS | 2,735 | Direct | COM | $28.20 | $77,127.00 | 95,833 |
| 09/18/2024 | DDS | 1,390 | Direct | COM | $34.55 | $48,024.50 | 98,568 |
| 09/11/2024 | DDS | 1,468 | Direct | COM | $31.89 | $46,814.52 | 99,958 |
| 09/06/2024 | DDS | 124,374 | Direct | COM | $32.14 | $3,997,380.36 | 103,126 |
| 09/06/2024 | DDS | 1,700 | Direct | COM | $32.63 | $55,471.00 | 101,426 |
| 08/19/2024 | DDS | 2,442 | Direct | COM | $45.01 | $109,914.42 | 111,332 |
| 08/19/2024 | DDS | 310 | Direct | COM | $46.00 | $14,260.00 | 111,022 |
| 06/11/2024 | DDS | 1,331 | Direct | COM | $31.34 | $41,713.54 | 113,774 |
| 06/10/2024 | DDS | 1,590 | Direct | COM | $30.23 | $48,065.70 | 115,105 |
| 05/16/2024 | DDS | 462 | Direct | COM | $28.59 | $13,208.58 | 116,695 |
| 05/16/2024 | DDS | 2,126 | Direct | COM | $28.20 | $59,953.20 | 117,157 |
| 03/11/2024 | DDS | 1,082 | Direct | COM | $25.70 | $27,807.40 | 120,873 |
| 03/11/2024 | DDS | 1,590 | Direct | COM | $24.99 | $39,734.10 | 119,283 |
| 03/08/2024 | DDS | 55,208 | Direct | COM | $26.72 | $1,475,157.76 | 122,244 |
| 03/08/2024 | DDS | 30,755 | Direct | COM | $25.31 | $778,409.05 | 177,452 |
| 03/08/2024 | DDS | 289 | Direct | COM | $27.33 | $7,898.37 | 121,955 |
| 03/07/2024 | DDS | 2,273 | Direct | COM | $25.85 | $58,757.05 | 121,955 |
| 03/01/2024 | DDS | 8,747 | Direct | COM | $28.22 | $246,840.34 | 124,792 |
| 03/01/2024 | DDS | 564 | Direct | COM | $28.65 | $16,158.60 | 124,228 |
| 02/29/2024 | DDS | 3,429 | Direct | COM | $27.50 | $94,297.50 | 124,228 |
| 01/26/2024 | DDS | 13,000 | Direct | COM | $24.34 | $316,420.00 | 124,228 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research